RIFAMPICINA ARENA 150mg capsules medication leaflet

J04AB02 rifampicin • Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Antibiotics

Rifampicin is an antibiotic primarily used to treat tuberculosis and other severe bacterial infections, such as leprosy or infections caused by Staphylococcus aureus. It belongs to the rifamycin class and works by inhibiting bacterial RNA synthesis, effectively killing the bacteria.

It is an essential medication in tuberculosis treatment, used in combination with other antibiotics to prevent bacterial resistance. Rifampicin is also used to prevent bacterial meningitis in individuals exposed to Neisseria meningitidis.

Side effects may include nausea, abdominal pain, orange discoloration of urine, tears, or saliva, and, more rarely, liver function impairment. Patients must strictly follow the prescribed treatment regimen to avoid the development of bacterial resistance.

Rifampicin should not be used without medical supervision, as it interacts with many other medications and may reduce their effectiveness.

General data about RIFAMPICINA ARENA 150mg

Substance: rifampicin

Date of last drug list: 01-04-2026

Commercial code: W60378002

Concentration: 150mg

Pharmaceutical form: capsules

Quantity: 1000

Product type: generic

Price: 395.10 RON

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer: ARENA GROUP SA - ROMANIA

Holder: ARENA GROUP SA - ROMANIA

Number: 4354/2004/02

Shelf life: 3 years

Concentrations available for rifampicin

150mg, 300mg

Other substances similar to rifampicin